Skip to main content

Opdualag Prices, Coupons and Patient Assistance Programs

Opdualag (nivolumab/relatlimab) is a member of the antineoplastic combinations drug class and is commonly used for Melanoma.

The cost for Opdualag intravenous solution (rmbw 240 mg-80 mg/20 mL) is around $15,012 for a supply of 20 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Opdualag prices

Intravenous Solution

Quantity Per unit Price
20 milliliters $750.61 $15,012.14

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Opdualag Coupons, Copay Cards and Rebates

Opdualag offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional. Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Opdualag BMS Oncology Co-Pay Assistance Program

Eligible commercially insured patients may pay as little as $0 per infusion with savings of up to $25,000 per calendar year; enrollment period is 1 calendar year; for additional information contact the program at 800-861-0048.

Applies to:
Number of uses:
Per prescription per calendar year

Form more information phone: 800-861-0048 or Visit website

Patient Assistance & Copay Programs for Opdualag

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Opdualag (nivolumab-relatlimab-rmbw) Injection

More information please phone: 866-316-7263 Visit Website

Provider: Bristol Myers Squibb (BMS) Access Support

Eligibility requirements:
  1. Contact program for details.
  2. Not disclosed
  3. Medically Necessary as determined by a Doctor
  4. Must be residing in the US or Puerto Rico
  5. *This program provides the screening for the Bristol-Myers Squibb Patient Assistance Foundation (BMSPAF) Oncology Patient Assistance Program. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. Please refer to the Enrollment Form to ensure the correct Fax number and address is used for your medication.
Applicable drugs:
  • Opdualag (nivolumab-relatlimab-rmbw) Injection

More information please phone: 800-861-0048 Visit Website